5-(2-chlorophenyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 250mg

1-(2-Fluorophenyl)-2-methylpropan-1-one, 95.0%, 5g

(2-Phenyloxazol-4-yl)methanol, 97%, 5g

4-Bromo-3,5-difluorobenzoic acid, 95.0%, 5g

N-Boc-exo-1-aminotropane, 90.0%, 1g

2-Chloroquinoline-3-boronic acid, 97.0%, 25g

(1-((Dimethylamino)methyl)cyclopropyl)methanol, 95%, 5g

4-Methoxybenzo[d]thiazole, 95.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 95.0%, 10g

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)

Methyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate dihydrochloride, 98%, 250mg

1-[(benzyloxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid, 100mg

Pyrido[2,3-b]pyrazine, 97.0%, 25g